DNIB Unwind, Inc.
(Other OTC/NBB : BIND)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.14%89.661.3%$813.14m
AMGNAmgen Inc.
1.42%188.141.2%$637.94m
GILDGilead Sciences, Inc.
0.35%65.780.9%$483.98m
BIIBBiogen Inc.
0.99%324.341.3%$431.66m
ILMNIllumina, Inc.
1.40%301.033.5%$315.70m
REGNRegeneron Pharmaceuticals, Inc.
1.01%422.842.6%$293.10m
VRTXVertex Pharmaceuticals Incorporated
0.81%184.551.9%$255.65m
ALXNAlexion Pharmaceuticals, Inc.
0.93%128.732.0%$221.71m
SRPTSarepta Therapeutics, Inc.
1.46%138.5415.4%$154.56m
AAgilent Technologies, Inc.
0.06%77.941.6%$150.90m
EXASExact Sciences Corporation
8.55%90.4025.3%$143.59m
INCYIncyte Corporation
0.95%84.122.5%$113.00m
ARRYArray BioPharma Inc.
3.61%23.538.2%$111.91m
EXELExelixis, Inc.
0.85%21.406.4%$82.76m
NBIXNeurocrine Biosciences, Inc.
1.28%78.305.1%$78.21m

Company Profile

DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Cambridge, MA.